Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $256.0.

  • Mangoceuticals' Depreciation & Amortization (CF) fell 9259.47% to $256.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1013.0, marking a year-over-year decrease of 9365.8%. This contributed to the annual value of $9936.0 for FY2024, which is 6007.87% down from last year.
  • As of Q3 2025, Mangoceuticals' Depreciation & Amortization (CF) stood at $256.0, which was down 9259.47% from $252.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Depreciation & Amortization (CF) peaked at $12515.0 during Q3 2023, and registered a low of $250.0 during Q1 2025.
  • For the 3-year period, Mangoceuticals' Depreciation & Amortization (CF) averaged around $4180.7, with its median value being $4769.5 (2023).
  • Per our database at Business Quant, Mangoceuticals' Depreciation & Amortization (CF) surged by 233.48% in 2024 and then plummeted by 9598.33% in 2025.
  • Over the past 3 years, Mangoceuticals' Depreciation & Amortization (CF) (Quarter) stood at $6292.0 in 2023, then plummeted by 95.95% to $255.0 in 2024, then grew by 0.39% to $256.0 in 2025.
  • Its last three reported values are $256.0 in Q3 2025, $252.0 for Q2 2025, and $250.0 during Q1 2025.